Thor Medical ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-58.91	-42.21	-26.56	-
Depreciation & Amortization	12.18	2.38	0.33	-
Stock-Based Compensation	4.01	2.81	2.1	-3.3
Other Operating Activities	-4.23	-2.03	17.03	-5.46
Change in Accounts Payable	19.23	13.13	-	-
Change in Other Net Operating Assets	-14.05	1.95	-32.4	-97.98
Operating Cash Flow	-44.48	-23.98	-64.09	-409.08
Capital Expenditures	-29.74	-0.14	-	-5.63
Cash Acquisitions	-	-	4.26	-
Other Investing Activities	2	1.7	2.02	3.16
Investing Cash Flow	-27.74	1.56	6.28	-2.46
Long-Term Debt Repaid	-	-0.48	-0.16	-5.52
Net Debt Issued (Repaid)	-1.08	-0.48	-0.16	-5.52
Issuance of Common Stock	285.25	114.35	0.15	250.81
Other Financing Activities	-17.12	-9.82	-0.32	-17.16
Financing Cash Flow	267.04	104.04	-0.33	228.13
Foreign Exchange Rate Adjustments	-	-	1.2	4.43
Miscellaneous Cash Flow Adjustments	-0	-0	0	-
Net Cash Flow	194.82	81.62	-56.95	-178.99
Free Cash Flow	-74.22	-24.12	-64.09	-414.71
Free Cash Flow Per Share	-0.27	-0.10	-0.37	-3.60
Cash Interest Paid	0.3	0.1	-	0.07
Cash Income Tax Paid	-	-	0.76	1.1
Levered Free Cash Flow	-50.59	-6.49	-34.91	-
Unlevered Free Cash Flow	-50.46	-6.42	-34.91	-
Change in Working Capital	2.47	15.07	-32.4	-97.98

Source: S&P Capital IQ. Standard template. Financial Sources.